Skip to main content
. 2019 Jun 2;10(12):2836–2848. doi: 10.7150/jca.31361

Table 1.

The dysregulated miR-27a and its targets in various cancers.

Diseases Targeted gene References
NSCLC MET, EGFR Acunzo et al (31)
hepatocellular carcinoma (HCC) FOXO1 Sun et al(34)
PPARγ Li et al(35)
prostate cancer(PCa) PHB Claire E. Fletcher et al(38)
RUNX-1 Deng et al(13)
COUP-TFII Lin et al(42)
renal cell carcinoma EGFR Li et al(16)
esophageal squamous cell carcinoma FBXW7 Wu et al(40)
colon cancer SGPP1,Smad2 Bao et al(25)
Calreticulin TColangelo et al(19)
cervical cancer B4GALT3 Sun et al(23)
oral squamous cell carcinoma YAP1 Zeng et al(41)
MCPH1 Thejaswini Venkatesh et al(33)
breast cancer SPRY2 Li et al(20)
TMEM170B Li et al(18)
BAK Zhou et al(70)
gastric cancer P21 Zhao et al(26)
ovarian tumor ZBTB10 Lai et al(58)
tumors or ischemic diseases SEMA6A Carmen Urbich et al(44)
osteosarcoma CBFA2T3 Zaidoun Salah1 et al(43)
bronchial cancer Fbxw7 Wang et al(22)
Glioblastoma (GBM) MXI1 Xu et al(29)
esophageal squamous cell carcinoma KRAS Jiang et al(17)
hepatocellular carcinoma (HCC) P21 Sun et al(34)
VE-cadherin Jennifer A. Young et al(55)
bladder urothelial carcinoma SLC7A11 Ross M Drayton et al(72)